(NASDAQ: NGNE) Neurogene's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.42%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.98%.
Neurogene's earnings in 2025 is -$71,132,000.On average, 5 Wall Street analysts forecast NGNE's earnings for 2025 to be -$60,547,859, with the lowest NGNE earnings forecast at -$66,697,715, and the highest NGNE earnings forecast at -$47,386,573.
In 2026, NGNE is forecast to generate -$79,027,137 in earnings, with the lowest earnings forecast at -$88,534,161 and the highest earnings forecast at -$69,520,113.